Piperacilline-Tazobactam Labatec i.v. 4 g - 0,5 g, poudre pour solution pour perfusion

7680601420037 CH-60142 Puder
Piperacilline-Tazobactam Labatec i.v. 4 g - 0,5 g, poudre pour solution pour perfusion
Piperacilline-Tazobactam Labatec i.v. 4 g - 0,5 g, poudre pour solution pour perfusion
Piperacilline-Tazobactam Labatec i.v. 4 g - 0,5 g, poudre pour solution pour perfusion
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Durchstechflasche(n)
Galenic form
Puder
Galenic group
Spray/Puder

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/01/2025
Summary of Product Characteristics
Français
29/01/2025
Summary of Product Characteristics
Italien
29/01/2025

Detailed composition

Substance Quantity Type Category
PRC
4.0 G Substance Wirkstoff (Principe actif)
PRC
- Substance WIZUS
PRC
0.5 G Substance Wirkstoff (Principe actif)
PRC
- Substance WIZUS
PRC
216.0 MG Substance HBESI

Reimbursement information

Public price
CHF 228.40
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/03/2022

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
60142
Drug name
Piperacilline-Tazobactam Labatec i.v., poudre pour solution pour perfusion
Galenic form
PULVI
ATC Code
J01CR05
Authorization status
Z
Dispensing category
A
First authorization
03/12/2010
Authorization expiration date
31/12/9999
IT Number
08.01.93
Domain
Human medicine

Package details

Description (FR)
PIPERACILLIN TAZOB. Labatec 4.5 g flac 10 pce
Description (DE)
PIPERACILLIN TAZOB. Labatec 4.5 g Durchstf 10 Stk
Market launch
03/12/2010
Narcotic (BTM)
No

Other package sizes (2)

PIPERACILLIN TAZOB. Labatec 2.25 g flac
1 DUR
GTIN: 7680601420013
View
PIPERACILLIN TAZOB. Labatec 4.5 g flac
1 DUR
GTIN: 7680601420020
View